AddLife AB (publ) (ADDLF) Stock
AddLife AB (publ) is a prominent supplier of specialized equipment, medical devices, and reagents. The company primarily caters to healthcare systems, research organizations, and academic institutions, while also serving the food and pharmaceutical industries.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About AddLife AB (publ)
AddLife AB (publ) is a prominent supplier of specialized equipment, medical devices, and reagents. The company primarily caters to healthcare systems, research organizations, and academic institutions, while also serving the food and pharmaceutical industries. Its operations are structured into two distinct segments: Labtech and Medtech. The Labtech segment delivers products, complete solutions, and services crucial for diagnostics, biomedical research, and laboratory work. This includes offerings across a broad spectrum such as haematology, pathology, point-of-care diagnostics, cell biology, genetics, microbiology, virology, molecular biology, clinical chemistry, and immunology, alongside consumables and analytical instruments. Additionally, this division provides essential support, maintenance, advisory, and training services. Conversely, the Medtech segment offers medical devices designed for diverse applications, including surgery, respiratory support, intensive care, wound treatment, enteral nutrition, fall prevention, and welfare technology. This also extends to assistive devices for ear, nose, and throat care, as well as bathroom aids and equipment tailored for children with disabilities. With a rich history dating back to its founding in 1906, AddLife AB (publ) is headquartered in Stockholm, Sweden, and operates extensively across Sweden, Finland, Denmark, Norway, the United Kingdom, Ireland, Germany, Italy, Austria, Switzerland, other European countries, and on an international scale.
AddLife AB (publ) is headquartered in SE.
AddLife AB (publ) (ADDLF) stock trades at $15.75 with a market capitalization of $1.85B. The stock is valued at a price-to-earnings (P/E) ratio of 31.84, price-to-book of 3.33, price-to-sales of 1.73. Over the past 52 weeks the stock has ranged between $7.94 and $42.00, and currently trades 62.5% below its 52-week high. It pays a dividend yielding 1.02%.
On profitability, AddLife AB (publ) generates a return on equity (ROE) of 10.82%, return on capital employed of 8.91%, an operating margin of 7.69%, a net profit margin of 5.68%.
Official website: www.add.life